4//SEC Filing
IRONWOOD PHARMACEUTICALS INC 4
Accession 0001209191-17-014370
$IRWDCIK 0001446847operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:37 PM ET
Size
10.2 KB
Accession
0001209191-17-014370
Insider Transaction Report
Form 4
Graney Thomas
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2017-02-22$16.94/sh−1,417$24,004→ 20,763 total - Sale
Class A Common Stock
2017-02-22$16.94/sh−457$7,742→ 22,180 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 16, 2015.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $17.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 1, 2016.
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001446847
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:37 PM ET
- Size
- 10.2 KB